Ligand profile
PPJ
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_02775 — Cystathionine beta-lyase metC
Identifiers
Database identifiers and provenance.
- Ligand ID
PPJ- PDB
1e5e- UniProt (similar protein)
A2FEV4- Target protein
- KP13_02775
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 169.8
- −1 ≤ LogP ≤ 5 0.35
- MW ≤ 500 Da 362.3
- LogP ≤ 5 0.35
- H-bond donors ≤ 5 5
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 169.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1c(c(c(cn1)COP(=O)(O)O)\C=N\[C@@H](C[C@H](C)O)C(=O)O)OCc1c(c(c(cn1)COP(=O)(O)O)\C=N\[C@@H](C[C@H](C)O)C(=O)O)O
InChI=1S/C13H19N2O8P/c1-7(16)3-11(13(18)19)15-5-10-9(6-23-24(20,21)22)4-14-8(2)12(10)17/h4-5,7,11,16-17H,3,6H2,1-2H3,(H,18,19)(H2,20,21,22)/b15-5+/t7-,11-/m0/s1InChI=1S/C13H19N2O8P/c1-7(16)3-11(13(18)19)15-5-10-9(6-23-24(20,21)22)4-14-8(2)12(10)17/h4-5,7,11,16-17H,3,6H2,1-2H3,(H,18,19)(H2,20,21,22)/b15-5+/t7-,11-/m0/s1
XZPXXYMXESJHME-PMICCBOBSA-NXZPXXYMXESJHME-PMICCBOBSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF01053
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand PPJ →
- PDB RCSB structure 1e5e →
- UniProt UniProt A2FEV4 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “PPJ”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02775.
PDB 16
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 4
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).